Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

Author： Williams David R.

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.130, Iss.6, 2007-06, pp. : 1566-1576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

By Williams David R.

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1247-1258

Oxford University Press

Access to resources Recommend Favorite

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

By Ling Helen

Brain, Vol. 135, Iss. 4, 2012-06 ,pp. : 1141-1153

Oxford University Press

Access to resources Recommend Favorite

The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK

By Nath U.

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1438-1449

Oxford University Press

Access to resources Recommend Favorite

Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP–parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al . ( Brain -2004-01045.R1)

By Burn David J.

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1235-1236

Oxford University Press

Access to resources Recommend Favorite

Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy

By Miyaoka Tsuyoshi Seno Haruo Inagaki Takuji Horiguchi Jun

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-03 ,pp. : 45-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite